Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: A case report

被引:5
|
作者
Tucker M.G. [1 ]
Kekulawala S. [1 ]
Kent M. [1 ]
Mostafa S. [2 ]
Harvey R. [1 ,3 ]
机构
[1] Mental Health, Drugs and Alcohol Service, Barwon Health, University Hospital Geelong, Geelong, VIC
[2] GenesFX Health, North Melbourne, VIC
[3] School of Medicine, Deakin University, Waurn Ponds, VIC
关键词
Medication safety; Methamphetamine; Pharmacogenetic testing; Psychiatric emergencies; Rapid sedation; Substance-induced psychosis;
D O I
10.1186/s13256-016-1031-3
中图分类号
学科分类号
摘要
Background: The high prevalence of comorbid illicit drug use in persons with chronic psychotic illness represents a strong determinant of psychotic relapse and rehospitalization. Epidemiological studies indicate changing patterns of illicit drug use in Australia, which are concerning because of increased use of crystal methamphetamine, also known as "ice." An important complication of habitual use of crystal methamphetamine is the development of a dose-dependent acute psychotic reaction. We report a case of an acute psychotic relapse in response to polydrug use most notable for multiple recent binges of crystal methamphetamine. Unlike previously described case reports, our patient's acute psychosis was refractory to ultra-high doses of multiple antipsychotic medications. This presented safety challenges due to the risk of serious side effects with high-dose antipsychotic medications. Case presentation: A 30-year-old white man with a past history of schizoaffective disorder was brought to our emergency department by the police in a state of extreme agitation, combativeness, and paranoia after use of cannabis and crystal methamphetamine. Despite existing compliance with zuclopenthixol decanoate depot medication, he required multiple emergency injections of zuclopenthixol acetate, and regular high-dose droperidol, chlorpromazine, and lorazepam. However, he remained severely agitated and psychotic with continuous threats of harm to others. A test of antipsychotic drug metabolism by cytochrome P450 enzymes did not reveal a pharmacogenetic cause for the poor therapeutic efficacy of antipsychotic medications. His psychosis did not appear to be modified by psychoactive medications but was instead self-limited to the presence of endogenous methamphetamine within his system. He fully recovered 96 to 120 hours post-presentation and was discharged home with out-patient clinic follow-up. Conclusions: The current case highlights the challenging nature of a severe psychotic relapse precipitated by illicit substances that is resistant to medical management. High doses of multiple antipsychotic medications may be required to manage dangerous behaviors associated with these acute psychotic relapses. These patients require close monitoring for adverse effects with adjustment of dosing to ensure the optimal balance of risk versus benefit while the patient is acutely psychotic. The results are of relevance for the management of psychiatric emergencies in emergency departments and acute mental health settings. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature
    Fan, Qiaomei
    Huang, Wei
    Weng, Yayun
    Xie, Xianze
    Shi, Zheng
    MEDICINE, 2020, 99 (43) : E22638
  • [22] Mania induced by quetiapine in patients with schizoaffective disorder, depressive type: a case report
    Nicolato, Rodrigo
    Ferreira, Rodrigo de Almeida
    Fonseca, Eduardo Villar
    Fonseca, Sarah Goncalves
    Amaral, Tammy da Silva
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2009, 31 (03) : 286 - 287
  • [23] Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report
    Tien, Yun
    PHARMACOPSYCHIATRY, 2023, 56 (05) : 204 - 205
  • [24] Successful Treatment of a Seizure Disorder with Chronic High-Dose Chloral Hydrate: A pediatric case report
    Vaillancourt, Regis
    Collins, Michael
    Vadeboncoeur, Chris
    Jacob, Pierre
    Graham, Nancy
    Foster, Donna
    Splinter, William
    JOURNAL OF PALLIATIVE CARE, 2010, 26 (04) : 311 - 313
  • [25] High-dose praziquantel with cimetidine for refractory neurocysticercosis: A case report with clinical and MRI follow-up
    Yee, T
    Barakos, JA
    Knight, RT
    WESTERN JOURNAL OF MEDICINE, 1999, 170 (02): : 112 - 115
  • [26] Iatrogenic Propylene Glycol Intoxication Due to High-Dose Pentobarbital for Refractory Intracranial Hypertension: A Case Report
    Smedley, Lucas W.
    Rios, Denise
    Barthol, Colleen A.
    Garvin, Rachel E.
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (06) : 895 - 898
  • [27] Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil - A case report
    Dillon, WC
    Hadian, D
    Ritchie, ME
    ANGIOLOGY, 2001, 52 (02) : 137 - 141
  • [28] Suicide Attempt With High-Dose Trimetazidine: Case Report
    Demirci, Hakan
    Kuecuekardali, Yasar
    Terekeci, Hakan
    Solmazguel, Emrullah
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2008, 25 (03): : 249 - 251
  • [29] High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor
    Connell, Brendan J.
    Patel, Manisha J.
    Tretter, Christopher G.
    CLINICAL GENITOURINARY CANCER, 2016, 14 (04) : E441 - E443
  • [30] Corticosteroid-induced bradycardia following high-dose methylprednisolone administration: a case report
    Zkib, Jwil
    Sattout, Raneem
    Faour, Sabah
    Haddad, Sultaneh
    Bassut, Ranim
    Swed, Wajd
    Hritani, Shahd
    Mansouer, Milad
    Ghabally, Mike
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (10): : 6300 - 6302